Vaxart Inc. announced that it has received a delisting notice from The Nasdaq Stock Market due to its failure to meet the minimum bid price requirement of $1.00 per share for its common stock. Despite being granted an additional compliance period until June 30, 2025, the company was unable to regain compliance. Consequently, Vaxart's stock is set to be delisted, with trading to be suspended on July 8, 2025. The company plans to transition its stock to the over-the-counter market under the symbol "VXRT" and has applied to be traded on the OTCQX tier, although approval is not guaranteed.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。